New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Kohrt, Holbrook E ^a   Olshen, Richard A ^a,b   Bermas, Honnie R ^c   Goodson, William H ^d   Wood, Douglas J ^a   Henry, Solomon ^a   Rouse, Robert V ^a   Bailey, Lisa ^e   Philben, Vicki J ^f   Dirbas, Frederick M ^a   Dunn, Jocelyn J ^a   Johnson, Denise L ^a   Wapnir, Irene L ^a   Carlson, Robert W ^a   Stockdale, Frank E ^a   Hansen, Nora M ^c   Jeffrey, Stefanie S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e ALTA BATES SUMMIT MEDICAL CENTER   (United States)

^f Mercy Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CALCULATOR; CANCER INVASION; CANCER PATIENT; COMPUTER MODEL; COMPUTER PREDICTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; ONLINE ANALYSIS; PAGET NIPPLE DISEASE; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; UNITED STATES; ALGORITHM; BLOOD VESSEL; BREAST TUMOR; EVALUATION; FEMALE; LYMPHADENECTOMY; METASTASIS; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ONLINE SYSTEM; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; THEORETICAL MODEL;

ALGORITHMS; BLOOD VESSELS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MODELS, THEORETICAL; MULTICENTER STUDIES AS TOPIC; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NOMOGRAMS; ONLINE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENTINEL LYMPH NODE BIOPSY; TUMOR BURDEN;

EID: 42449141922     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-66     Document Type: Article

References (64)

1. Lyman GH Giuliano AE Somerfield MR Benson AB 3rd Bodurka DC Burstein HJ Cochran AJ Cody HS 3rd Edge SB Galper S Hayman JA Kim TY Perkins CL Podoloff DA Sivasubramaniam VH Turner RR Wahl R Weaver DL Wolff AC Winer EP American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 2005, 23(30):7703-7720. 10.1200/JCO.2005.08.001 16157938
2. Rubio IT Korourian S Cowan C Krag DN Colvert M Klimberg VS Sentinel lymph node biopsy for staging breast cancer Am J Surg 1998, 176(6):532-537. 10.1016/S0002-9610(98)00264-5 9926785
3. Carlson RW McCormick B Update: NCCN breast cancer Clinical Practice Guidelines J Natl Compr Canc Netw 2005, 3(Suppl 1):S7-11. 16280118
4. Sosa JA Diener-West M Gusev Y Choti MA Lange JR Dooley WC Zeiger MA Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer Ann Surg Oncol 1998, 5(2):140-149. 10.1007/BF02303847 9527267
5. Chu KU Turner RR Hansen NM Brennan MB Bilchik A Giuliano AE Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999, 229(4):536-541. 1191740 10203087 10.1097/00000658-199904000-00013
6. Turner RR Chu KU Qi K Botnick LE Hansen NM Glass EC Giuliano AE Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node Cancer 2000, 89(3):574-581. 10.1002/ 1097-0142(20000801)89:3<574::AID-CNCR12>3.0.CO;2-Y 10931456
7. Rietman JS Dijkstra PU Geertzen JH Baas P De Vries J Dolsma W Groothoff JW Eisma WH Hoekstra HJ Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma Cancer 2003, 98(4):690-696. 10.1002/cncr.11545 12910511
8. Hack TF Cohen L Katz J Robson LS Goss P Physical and psychological morbidity after axillary lymph node dissection for breast cancer J Clin Oncol 1999, 17(1):143-149. 10458227
9. Mansel RE Fallowfield L Kissin M Goyal A Newcombe RG Dixon JM Yiangou C Horgan K Bundred N Monypenny I England D Sibbering M Abdullah TI Barr L Chetty U Sinnett DH Fleissig A Clarke D Ell PJ Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial J Natl Cancer Inst 2006, 98(9):599-609. 16670385
10. Reynolds C Mick R Donohue JH Grant CS Farley DR Callans LS Orel SG Keeney GL Lawton TJ Czerniecki BJ Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999, 17(6):1720-1726. 10561208
11. Abdessalam SF Zervos EE Prasad M Farrar WB Yee LD Walker MJ Carson WB Burak WE Jr. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer Am J Surg 2001, 182(4):316-320. 10.1016/S0002-9610(01)00719-X 11720662
12. Rahusen FD Torrenga H van Diest PJ Pijpers R van der Wall E Licht J Meijer S Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer Arch Surg 2001, 136(9):1059-1063. 10.1001/archsurg.136.9.1059 11529831
13. Van Zee KJ Manasseh DM Bevilacqua JL Boolbol SK Fey JV Tan LK Borgen PI Cody HS 3rd Kattan MW A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 2003, 10(10):1140-1151. 10.1245/ ASO.2003.03.015 14654469
14. Smidt ML Kuster DM van der Wilt GJ Thunnissen FB Van Zee KJ Strobbe LJ Can the Memorial Sloan-Kettering Cancer Center Nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005, 12(12):1066-1072. 10.1245/ASO.2005.07.022 16244802
15. Specht MC Kattan MW Gonen M Fey J Van Zee KJ Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram Ann Surg Oncol 2005, 12(8):654-659. 10.1245/ ASO.2005.06.037 16021535
16. Park J Fey JV Naik AM Borgen PI Van Zee KJ Cody HS 3rd A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram Ann Surg 2007, 245(3):462-468. 1877014 17435554 10.1097/ 01.sla.0000250439.86020.85
17. Kocsis L Svebis M Boross G Sinko M Maraz R Rajtar M Cserni G Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients Am J Surg 2004, 70(11):1019-1024. 15586519
18. Degnim AC Reynolds C Pantvaidya G Zakaria S Hoskin T Barnes S Roberts MV Lucas PC Oh K Koker M Sabel MS Newman LA Nonsentinel node metastasis in breast cancer patients: Assessment of an existing and a new predictive nomogram Am J Surg 2005, 190(4):543-550. 10.1016/j.amjsurg.2005.06.008 16164917
19. Alran S De Rycke Y Fourchotte V Charitansky H Laki F Falcou MC Benamor M Freneaux P Salmon RJ Sigal-Zifrani B Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy Ann Surg Oncol 2007, 14(8):2195-2201. 10.1245/s10434-006-9331-2 17294071
20. Cody HS 3rd Borgen PI State-of-the-art approaches to sentinel node biopsy for breast cancer: Study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center Surg Oncol 1999, 8(2):85-91. 10.1016/S0960-7404(99)00029-8 10732960
21. Cserni G Amendoeira I Apostolikas N Bellocq JP Bianchi S Bussolati G Boecker W Borisch B Connolly CE Decker T Dervan P Drijkoningen M Ellis IO Elston CW Eusebi V Faverly D Heikkila P Holland R Kerner H Kulka J Jacquemier J Lacerda M Martinez-Penuela J De Miguel C Peterse JL Rank F Regitnig P Reiner A Sapino A Sigal-Zafrani B Tanous AM Thorstenson S Zozaya E Wells CA Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines Eur J Cancer 2003, 39(12):1654-1667. 10.1016/ S0959-8049(03)00203-X 12888359
22. Elston CW Ellis IO Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 1991, 19(5):403-410. 10.1111/j.1365-2559.1991.tb00229.x 1757079
23. Singletary SE Greene FL Sobin LH Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual Cancer 2003, 98(12):2740-2741. 10.1002/cncr.11865 14669301
24. Breiman L Friedman JH Olshen RA Stone CJ Classification and Regression Trees Belmont, CA, Wadsworth 1984
25. Dalgaard P Introductory Statistics with R USA, Springer 2002
26. Kraemer HC Evaluating medical tests: Objective and quantitative guidelines Newbury Park, CA., Sage Publications 1992
27. Hastie T Tibshirani R Friedman JH The Elements of Statistical Learning USA, Springer 2001
28. Kwak LW Halpern J Olshen RA Horning SJ Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis J Clin Oncol 1990, 8(6):963-977. 2348230
29. ROC software, Sierra-Pacific MIRECC http://mirecc.stanford.edu/
30. CART software, Salford Systems http://www.salford-systems.com/cart.php
31. McLachlan G Discriminant Analysis and Statistical Pattern Recognition USA, John Wiley and Sons, Inc. 1992
32. Stone CJ A Course in Probability and Statistics Belmont, CA, Duxbury Press 1995
33. Team RDC R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing 2006 http://www.R-project.org 16835509
34. DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach Biometrics 1988, 44(3):837-845. 10.2307/2531595 3203132
35. Veronesi U Paganelli G Viale G Luini A Zurrida S Galimberti V Intra M Veronesi P Robertson C Maisonneuve P Renne G De Cicco C De Lucia F Gennari R A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 2003, 349(6):546-553. 10.1056/NEJMoa012782 12904519
36. Esserman L Sepucha K Practice implications of the high false negative rate of sentinel lymph node biopsy reported in NSABP-32 J Clin Oncol 2005, 23(16S):812
37. Veronesi U Paganelli G Viale G Luini A Zurrida S Galimberti V Intra M Veronesi P Maisonneuve P Gatti G Mazzarol G De Cicco C Manfredi G Fernandez JR Sentinel-lymph-node biopsy as a staging procedure in breast cancer: Update of a randomised controlled study Lancet Onc 2006, 7(12):983-990. 10.1016/S1470-2045(06)70947-0
38. van Rijk MC Peterse JL Nieweg OE Oldenburg HS Rutgers EJ Kroon BB Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes Cancer 2006, 107(3):467-471. 10.1002/cncr.22069 16804924
39. Orr RK The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis Ann Surg Oncol 1999, 6(1):109-116. 10.1007/s10434-999-0109-1 10030423
40. Krag DN Julian TB Harlow SP Weaver DL Ashikaga T Bryant J Single RM Wolmark N NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial Ann Surg Oncol 2004, 11(3 Suppl):208S-10S. 15023753
41. Grube BJ Giuliano AE Observation of the breast cancer patient with a tumor-positive sentinel node: Implications of the ACOSOG Z0011 trial Semin Surg Oncol 2001, 20(3):230-237. 10.1002/ssu.1038 11523108
42. Fant JS Grant MD Knox SM Livingston SA Ridl K Jones RC Kuhn JA Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection Ann Surg Oncol 2003, 10(2):126-130. 10.1245/ASO.2003.04.022 12620906
43. Wada N Imoto S Yamauchi C Hasebe T Ochiai A Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node Eur J Surg Oncol 2006, 32(1):29-33. 10.1016/j.ejso.2005.08.010 16269227
44. Kamath VJ Giuliano R Dauway EL Cantor A Berman C Ku NN Cox CE Reintgen DS Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: A study to evaluate the need for complete axillary lymph node dissection Arch Surg 2001, 136(6):688-692. 10.1001/archsurg.136.6.688 11387010
45. Yu JC Hsu GC Hsieh CB Sheu LF Chao TY Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan World J Surg 2005, 29(7):813-8. discussion 818-9 10.1007/s00268-005-7744-x 15951935
46. Viale G Maiorano E Pruneri G Mastropasqua MG Valentini S Galimberti V Zurrida S Maisonneuve P Paganelli G Mazzarol G Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy Ann Surg 2005, 241(2):319-325. 1356918 15650643 10.1097/01.sla.0000150255.30665.52
47. Bolster MJ Peer PGM Bult P Thunnissen FBJM Schapers RFM Meijer JWR Strobbe LJA van Berlo CLH Klinkenbijl JHG Beex LVAM Wobbes T Tjan-Heijnen VCG Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study Ann Surg Oncol 2007, 14(1):181-189. 10.1245/s10434-006-9065-1 17028772
48. Carcoforo P Maestroni U Querzoli P Lanzara S Maravegias K Feggi L Soliani G Basaglia E Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases World J Surg 2006, 30(9):1653-1657. 10.1007/ s00268-005-0083-0 16927059
49. Rivers AK Griffith KA Hunt KK Degnim AC Sabel MS Diehl KM Cimmino VM Chang AE Lucas PC Newman LA Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node Ann Surg Oncol 2006, 13(1):36-44. 10.1245/ASO.2006.03.080 16378156
50. Ozmen V Karanlik H Cabioglu N Igci A Kecer M Asoglu O Tuzlali S Mudun A Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer Breast Cancer Res Treat 2006, 95(1):1-6. 10.1007/ s10549-005-9007-9 16322900
51. Calhoun KE Hansen NM Turner RR Giuliano AE Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: Implications for completion axillary node dissection Am J Surg 2005, 190(4):588-591. 10.1016/j.amjsurg.2005.06.018 16164927
52. Cserni G Gregori D Merletti F Sapino A Mano MP Ponti A Sandrucci S Baltas B Bussolati G Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer Br J Surg 2004, 91(10):1245-1252. 10.1002/bjs.4725 15376203
53. Cserni G Bianchi S Vezzosi V Arisio R Bori R Peterse JL Sapino A Castellano I Drijkoningen M Kulka J Eusebi V Foschini MP Bellocq JP Marin C Thorstenson S Amendoeira I Reiner-Concin A Decker T Lacerda M Figueiredo P Fejes G Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study Path Onc Res 2007, 13(1):5-14
54. Kohrt HE Nouri N Nowels K Johnson D Holmes S Lee PP Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer PLoS Med 2005, 2(9):e284. 1198041 16124834 10.1371/ journal.pmed.0020284
55. Jeffrey SS Lonning PE Hillner BE Genomics-based prognosis and therapeutic prediction in breast cancer J Natl Compr Canc Netw 2005, 3(3):291-300. 16002001
56. Soni NK Carmalt HL Gillett DJ Spillane AJ Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity Eur J Surg Oncol 2005, 31(9):958-964. 15979270 10.1016/j.ejso.2005.04.011
57. Lambert LA Ayers GD Hwang RF Hunt KK Ross MI Kuerer HM Singletary SE Babiera GV Ames FC Feig B Lucci A Krishnamurthy S Meric-Bernstam F Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy Ann Surg Oncol 2006, 13(3):310-320. 10.1245/ASO.2006.03.078 16463073
58. Cripe MH Beran LC Liang WC Sickle-Santanello BJ The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: Validation of a nomogram Am J Surg 2006, 192(4):484. 10.1016/j.amjsurg.2006.06.016 16978955
59. Dauphine CE Haukoos JS Vargas MP Isaac NM Khalkhali I Vargas HI Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 2007, 14(3):1014-1019. 10.1245/s10434-006-9223-5 17176986
60. Ponzone R Maggiorotto F Mariani L Jacomuzzi ME Magistris A Mininanni P Biglia N Sismondi P Comparison of two models for the prediction of nonsentinel node metastases in breast cancer Am J Surg 2007 193 6 686 692 10.1016/j.amjsurg.2006.09.031 17512277
61. Surveillance Epidemiology and End Results Statistics http://seer.cancer.gov/
62. Hwang RF Krishnamurthy S Hunt KK Mirza N Ames FC Feig B Kuerer HM Singletary SE Babiera G Meric F Akins JS Neely J Ross MI Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer Ann Surg Oncol 2003, 10(3):248-254. 10.1245/ASO.2003.05.020 12679309
63. Barranger E Coutant C Flahault A Delpech Y Darai E Uzan S An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement Breast Cancer Res Treat 2005, 91(2):113-119. 10.1007/s10549-004-5781-z 15868438
64. Stanford Online Calculator http://www-stat.stanford.edu/~olshen/ NSLNcalculator/